Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.
Lawitz E, Bidair M, Marbury T, Jones CT, Barve A, Magnusson B, Barkan DT, Bodendorf U, Bracken K, Canino E, Chen D, Dabovic K, Heimbach T, Ison M, Jones CL, Kovacs SJ, Lakshman JP, Li B, Raman P, Steiner-Swiat R, Thohan S, Wong KA, Zhong W, Colvin RA. Lawitz E, et al. Among authors: kovacs sj. Clin Ther. 2018 Sep;40(9):1567-1581.e4. doi: 10.1016/j.clinthera.2018.07.019. Epub 2018 Sep 2. Clin Ther. 2018. PMID: 30185394 Clinical Trial.
A framework to guide dose & regimen strategy for clinical drug development.
Sander O, Magnusson B, Ludwig I, Jullion A, Meille C, Lorand D, Bornkamp B, Hinder M, Kovacs SJ, Looby M. Sander O, et al. Among authors: kovacs sj. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1276-1280. doi: 10.1002/psp4.12701. Epub 2021 Sep 25. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34562310 Free PMC article.
Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation.
Barrett JS, Bishai R, Bucci-Rechtweg C, Cheung A, Corriol-Rohou S, Haertter S, James A, Kovacs SJ, Liu J, Potempa D, Strougo A, Vanevski K; IQ consortium - CPLG Pediatric Working Group. Barrett JS, et al. Among authors: kovacs sj. Clin Pharmacol Ther. 2018 Mar;103(3):419-433. doi: 10.1002/cpt.1000. Epub 2018 Jan 31. Clin Pharmacol Ther. 2018. PMID: 29277892 Review.
Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
Sun H, Ting L, Machineni S, Praestgaard J, Kuemmell A, Stein DS, Sunkara G, Kovacs SJ, Villano S, Tanaka SK. Sun H, et al. Among authors: kovacs sj. Antimicrob Agents Chemother. 2016 Nov 21;60(12):7431-7435. doi: 10.1128/AAC.01393-16. Print 2016 Dec. Antimicrob Agents Chemother. 2016. PMID: 27736760 Free PMC article. Clinical Trial.
Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline.
Flarakos J, Du Y, Gu H, Wang L, Einolf HJ, Chun DY, Zhu B, Alexander N, Natrillo A, Hanna I, Ting L, Zhou W, Dole K, Sun H, Kovacs SJ, Stein DS, Tanaka SK, Villano S, Mangold JB. Flarakos J, et al. Among authors: kovacs sj. Xenobiotica. 2017 Aug;47(8):682-696. doi: 10.1080/00498254.2016.1213465. Epub 2016 Aug 8. Xenobiotica. 2017. PMID: 27499331
Correction for Kovacs et al., "An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline".
Kovacs SJ, Ting L, Praestgaard J, Sunkara G, Sun H, Stein DS, Tanaka SK, Villano S. Kovacs SJ, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e02426-20. doi: 10.1128/AAC.02426-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33328319 Free PMC article. No abstract available.
134 results